Table 1 Baseline characteristics (to be placed after line 240)
Parameter | ||
|---|---|---|
Demography | n | years, mean ± SD |
Age at registration | 865 | 34.4 ± 7.6 |
History of endometriosis (n = 865) | n | % women |
Onset of first symptomsa | ||
< 1 year ago | 402 | 46.5 |
Between 1 and 5 years ago | 259 | 29.9 |
> 5 years ago | 199 | 23.0 |
Missing | 5 | 0.6 |
Most common symptoms of endometriosisb | ||
Dysmenorrhea | 684 | 79.1 |
Chronic pelvic pain | 279 | 32.3 |
Dyspareunia | 51 | 5.9 |
Timepoint of first diagnosisa | ||
< 1 year ago | 644 | 74.5 |
Between 1 and 5 years ago | 135 | 15.6 |
> 5 years ago | 85 | 9.8 |
Missing | 1 | 0.1 |
Methods of diagnosis | ||
Surgical diagnosis | 616 | 71.2 |
Clinical diagnosis only | 247 | 28.6 |
Missing | 2 | 0.2 |
Endometriosis lesions (n = 768 evaluable patients) | ||
Single | 417 | 54.3 |
Multi | 351 | 45.7 |
Endometriosis localization2 | ||
Ovary | 640 | 88.4 |
Pelvic organ | 282 | 39.0 |
Extra pelvic | 21 | 2.9 |
r-ASRM stage of endometriosis (n = 246)c | n | % women |
Stage I (minimal) | 17 | 6.9 |
Stage II (mild) | 20 | 8.1 |
Stage III (moderate) | 86 | 35.0 |
Stage IV (severe) | 126 | 51.2 |
Most common previous diseases (n = 141)2 | n | % women |
Uterine leiomyoma | 69 | 48.9 |
Endometrial polyp | 36 | 25.5 |
Ovarian cysts | 26 | 18.4 |
Pelvic inflammatory disease | 20 | 14.2 |
Most common concomitant diseases (n = 146)2 | n | % women |
Adenomyosis | 46 | 31.5 |
Uterine leiomyoma | 39 | 26.7 |
Anemia | 18 | 12.3 |
Prior endometriosis treatment (n = 864 evaluable patients) | n | % women |
Patients with prior treatment | 514 | 59.5 |
Patients without prior treatment | 350 | 40.5 |
Type of treatment (n = 514) | n | % women |
Surgery | 449 | 87.4 |
Hormonal treatment | 179 | 34.8 |
Pain therapy | 89 | 17.3 |